Loading interface...

Telsar LN-5 Tablet

Manufactured byTORRENT PHARMACEUTICALS LTD
ContainsCilnidipine (5 mg) + Telmisartan (40 mg)
Description

Telsar LN-5 Tablet is a combination medicine used for the treatment of high blood pressure. Patients are advised to maintain a strict exercise and diet regimen along with this medicine to get the best possible effect.

Side effects

Major & minor side effects for Telsar LN-5 Tablet

  • Changes in vision
  • Dizziness
  • Increased heartbeat
  • Difficult or painful urination
  • Abdominal pain
  • Diarrhea
  • Back pain
  • Weakness
  • Muscle pain
  • Fever
  • Hypotension
  • Swelling of face, lips, eyelids, tongue, hands and feet
  • Shaking of hands or feet
  • Skin rash
  • Decreased sexual urge
  • Increased urination frequency
  • Chest pain

Uses of Telsar LN-5 Tablet

What is it prescribed for?

  • Hypertension
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 2 hours of administration of the dose.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains effective in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment of this medicine due to the increased risk of dizziness, fainting, and a very low blood pressure. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women except in life-threatening conditions. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to Cilnidipine, Telmisartan, or any other ingredients present in the formulation.

Heart diseases

This medicine is not recommended for use in patients having heart conditions like heart attack, rhythm disorders, angina, narrowing of blood vessels etc. due to the increased risk of worsening of the patient's condition.

Aliskiren

Coadministration of aliskiren and this combination medicine is not recommended due to the increased risk of serious adverse effects. This risk is especially higher in the elderly population and in patients with diabetes and kidney diseases.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women except in life-threatening conditions. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
General warnings

Aortic Stenosis

This medicine should be used with extreme caution in patients suffering from aortic stenosis due to the increased risk of a very low blood pressure. Close monitoring of blood pressure is recommended for such patients. An alternative treatment option should be considered in some cases based on the clinical condition.

Use in Children

This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.

Renal artery stenosis

This medicine should be used with caution in patients with renal artery stenosis due to the increased risk of severe adverse effects. Close monitoring of blood urea and serum creatinine levels is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Heart attack

This medicine should be used with caution while in patients with coronary artery diseases as it may worsen the symptoms of heart attack. The loading and maintenance doses are to be decided by the doctor based on the clinical evaluation of the condition.

Drug Withdrawal

Abrupt discontinuation of this medicine may increase the risk of increased chest pain (angina). A gradual dose reduction is recommended to avoid these reactions. Do not stop the use of this medicine without consulting your doctor.

Hyperkalemia

Use of this medicine may increase the potassium levels in the blood (hyperkalemia). This may cause serious side effects such as fatal cardiac rhythm irregularities. It is advised to avoid potassium-rich foods (potatoes, bananas) and other medicines that may increase potassium levels (potassium-sparing diuretics and potassium supplements) during treatment with this medicine.

Driving or Operating machinery

Use of this medicine may cause blurred vision or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment of this medicine due to the increased risk of dizziness, fainting, and a very low blood pressure. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine

Carbamazepine

Dexamethasone

Diclofenac

Captopril

Insulin

Primaquine

Cimetidine

Disease interactions

Congestive heart failure

This medicine should be used with caution in patients with congestive heart failure since it may worsen the patient's condition. Close monitoring of blood pressure, electrolytes level, and heart function are recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Hypotension or cardiogenic shock

This medicine is not recommended in patients suffering from low blood pressure or cardiogenic shock as it may further lower the blood pressure causing severe adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Kidney Disease

This medicine should be used with caution in patients who are suffering from kidney diseases due to the increased risk of adverse effects. Regular monitoring of the kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Liver Disease

This medicine should be used with caution in patients who are suffering from liver diseases due to the increased risk of adverse effects. Regular monitoring of the liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Consumption of grapefruit juice is not recommended while taking this medicine due to the increased risk of adverse effects. Symptoms like dizziness, headache, swelling of hands and feet should be reported to the doctor on priority.
Lab interactions

Urinary vanillylmandelic acid

Report the use of this medicine if you have been asked to undergo this test for the presence of adrenal gland tumor. Use of this medicine is likely to give the false value that might be higher than normal.
Take this medicine exactly as advised by your doctor. It can be taken with or without food. Do not take in larger amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Telmisartan works by blocking a receptor and prevents the blood vessel constriction. Cilnidipine acts by blocking the influx of calcium (responsible for contraction of blood vessels) and causes relaxation, thereby promoting the smooth flow of blood. Their combination is thus effective in reducing the blood pressure.
Legal Status

Unknown

Unknown

Unknown

Unknown

Classification

Category

Angiotensin II inhibitors with calcium channel blockers, Antihypertensive combinations

Schedule

Schedule H

Cilnidipine | C27H28N2O7 - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 14 August 2018]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/cilnidipine#section=Top

K. Sarat Chandra G. The fourth-generation Calcium channel blocker: Cilnidipine [Internet]. PubMed Central (PMC). 2017 [cited 14 August 2018]. Available from:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905258/

DailyMed - Telmisartan tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 14 August 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1a907a7-fad9-a860-8639-4c6136c85734
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 22 Apr 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.